Skip to content
  • HOME
  • ABOUT ACHIEVE
    • About Us
    • Management Team
    • Board of Directors
    • Careers
  • PRODUCTS
    • Cytisinicline
    • Phase 3 ORCA-2 Trial
    • Phase 2 ORCA-1 Trial
  • Achieve Life Sciences Logo Achieve Life Sciences Logo
  • NEWS
    • Press Releases
    • Events
    • Blog
  • INVESTORS
  • CONTACT
Loading...

Clinical Trials

Home/Clinical Trials
Clinical Trialsivps42020-09-21T19:16:04-05:00

Positive Phase 2b ORCA-1 Results Reported

Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial